Biognosys has launched its Proteome-SEQ protein biomarker discovery service, which the company said is intended for quantification of thousands of proteins in parallel across multiple samples.
The service uses hyper-reaction monitoring mass spec for large scale protein biomarker discovery. Currently it can be applied to human cell cultures and liver tissue samples.
Protagen has launched its ADx SSc Multilisa kit for the study of systemic sclerosis. Intended for research into autoimmune diseases, the kit contains assays to two proprietary markers along with two standard diagnostic markers.